CORDIS
EU research results

CORDIS

English EN

Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.

Project information

Grant agreement ID: 777450

Status

Ongoing project

  • Start date

    1 March 2018

  • End date

    31 August 2020

Funded under:

H2020-EU.3.1.7.

  • Overall budget:

    € 9 100 277,50

  • EU contribution

    € 4 498 931

Coordinated by:

FORUM EUROPEEN DES PATIENTS (FPE)

Luxembourg

Objective

PARADIGM will provide a unique framework that enables structured, effective, meaningful, ethical, innovative, and sustainable patient engagement (PE) and demonstrates the ‘return on the engagement’ for all players. Much needed processes and tools for three key decision-making points (research priority setting, design of clinical trials and early dialogue) will be developed by consensus. Building on advances at international level, PARADIGM will integrate the needs, perspectives and expectations of all actors (including vulnerable populations) involved and will also produce a stakeholder-tailored set of metrics to measure the impact of PE.
PARADIGM will deliver to the community, recommendations and tools to support the implementation of PE, leveraging pre-existing resources. These will address capacity and capability questions, managing potential conflict of interest, the compensation of individuals and organisations, and the ethics of engagement. A targeted communication, dissemination and engagement strategy will promote the endorsement of the outputs for their integration in existing structures.
PARADIGM will develop a strategy for sustaining the long-term implementation of PE resources aimed at structuring and supporting the community. This will be a game-changer, addressing fundamental gaps and creating real assets to ensure the sustainability of the PE ecosystem in the years to come.
PARADIGM has a common vision and values-base, and is a highly innovative, consensus-oriented, and experienced consortium, comprising pan-European leaders in patient engagement, academia, SMEs, health professionals, pharmaceutical and biotech companies, pharmaceutical corporate associations, and representatives of competent authorities, all bringing complementary know-how to partner with industry, and a strong commitment to transform patient engagement in Europe.

Coordinator

FORUM EUROPEEN DES PATIENTS (FPE)

Address

Rue Dicks 14
1417 Luxembourg

Luxembourg

Activity type

Other

EU Contribution

€ 702 516

Participants (33)

EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION

France

EU Contribution

€ 463 597

EUROPEAN AIDS TREATMENT GROUP EV

Germany

EU Contribution

€ 381 750

ALZHEIMER EUROPE

Luxembourg

EU Contribution

€ 248 500

AGENZIA ITALIANA DEL FARMACO

Italy

EU Contribution

€ 50 000

HEALTH TECHNOLOGY ASSESSMENT INTERNATIONAL SOCIETY

Canada

INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD

Spain

EU Contribution

€ 181 086

FUNDACIO SANT JOAN DE DEU

Spain

EU Contribution

€ 176 125

STICHTING VU

Netherlands

EU Contribution

€ 458 437

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

United Kingdom

EU Contribution

€ 621 592

EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE

Belgium

EU Contribution

€ 198 000

THE SYNERGIST

Belgium

EU Contribution

€ 543 828

SYNAPSE RESEARCH MANAGEMENT PARTNERS SL

Spain

EU Contribution

€ 473 500

FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES

Belgium

MERCK SHARP & DOHME CORP

United States

UCB BIOPHARMA SRL

Belgium

THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY

United Kingdom

AMGEN LIMITED

United Kingdom

BAYER AKTIENGESELLSCHAFT

Germany

GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

United Kingdom

GRUNENTHAL GMBH

Germany

JANSSEN PHARMACEUTICA NV

Belgium

Eli Lilly and Company Limited

United Kingdom

H. LUNDBECK AS

Denmark

MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

Germany

NOVO NORDISK A/S

Denmark

PFIZER LIMITED

United Kingdom

F. HOFFMANN-LA ROCHE AG

Switzerland

INSTITUT DE RECHERCHES INTERNATIONALES SERVIER

France

VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV

Germany

SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT

France

NOVARTIS PHARMA AG

Switzerland

COVANCE LABORATORIES LTD

United Kingdom

ALEXION SERVICES EUROPE SPRL

Belgium

Project information

Grant agreement ID: 777450

Status

Ongoing project

  • Start date

    1 March 2018

  • End date

    31 August 2020

Funded under:

H2020-EU.3.1.7.

  • Overall budget:

    € 9 100 277,50

  • EU contribution

    € 4 498 931

Coordinated by:

FORUM EUROPEEN DES PATIENTS (FPE)

Luxembourg